QUESTIONNAIRE-BASED STUDY ON THE ASSESSMENT OF DOCTOR OF PHARMACY INTERNS’ KNOWLEDGE, ATTITUDE, AND PRACTICES REGARDING THE PHARMACOVIGILANCE
Objectives: The present study was contemplated and done to assess the knowledge, attitude, and practices (KAP) toward adverse drug reactions (ADR) reporting and Pharmacovigilance (PV) of the Doctor of Pharmacy Pharm.D interns for the first time in South India, to get an insight into their awareness and reporting culture.
Methods: A cross-sectional descriptive KAP questionnaire-based study was conducted for 6 months on Pharm.D interns.
Results: A total of 603 Pharm.D interns were participated, among them 578 (95.85%) were considered for the analysis. On an average of 78.25% of the participants had a good knowledge, around 82% were aware that patients’ will be benefited from the ADR reporting. The majority of the participants had a positive attitude. Moreover, 59% had reported the ADRs through different ADR reporting procedures 52% were advised the awareness programs for improving the reporting culture, and 34% had the difficulty in deciding or diagnosing the ADR.
Conclusion: The KAP of the Pharm.D interns toward the ADR reporting and PV is appreciable and may reduce the burden on the other healthcare workers and improve patient care.
2. WHO: Essential Medicines and Health Products. Available from: https://www.who.int/medicines/news/glob_pharmvig_database_qa/en. [Last accessed on 2020 Apr 24].
3. Adverse Drug Reactions. Available form: https://www.google.com/url? sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&uact=8&ved= 2ahUKEwiqnarwhYvpAhXW7XMBHf2HD8AQFjADegQIAx AB&url=https%3A%2F%2Fwww.accp.com%2Fdocs%2Fbookstore% 2Fpsap%2F2015B2.SampleChapter.pdf&usg=AOvVaw0StpCVJE9qy EdheOdDmqWo. [Last accessed on 2020 Apr 21].
4. WHO: Policy Implementation Package for New TB Drug Introduction. Available from: https://www.who.int/tb/PIPnewTBdrugs.pdf. [Last accessed on 2020 Apr 27].
5. Saleh HA. Knowledge, attitude and practice of health professionals towards adverse drug reactions reporting. EJPMR 2016;3:12-21.
6. Gosh AK, De A, Bala NN. Current problems and future aspects of pharmacovigilance. Int J Pharm Bio Sci 2011;2:1528.
7. Alsaleh FM, Lemay J, Al Dhafeeri RR, AlAjmi S, Abahussain EA, Bayoudl T. Adverse drug reaction reporting among physicians working in private and government hospitals in Kuwait. Saudi Pharma J 2017;25:1184-93.
8. World Health Organization. WHO’s Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions. WHO/EDM/ QSM/2002. Geneva, Switzerland: World Health Organization; 2002.
9. Kalaiselvan V, Sushma S, Abhishank S, Suresh KG. Pharmacovigilance in India: Present scenario and future challenges. Drug Saf 2019;42:339-46.
10. PVPI: Introduction and Function. Available from: http://www.ipc.gov. in/PvPI/about.html. [Last accessed on 2020 Apr 28].
11. Komaram RB, Dhar M. A study on assessment of knowledge, attitude and practice regarding pharmacovigilance among healthcare professionals in a tertiary care hospital, Andhra Pradesh. Int J Pharm Sci Res 2016;7:5082-87.
12. Manjhi PK, Kumar M, Dikshit H, Mohan L, Mishra H. A survey on knowledge, attitude and practice of pharmacovigilance and adverse drug reaction reporting among healthcare professionals in a tertiary care hospital of Bihar, India. Int J Basic Clin Pharmacol 2016;5:2566-71.
13. Farha RA, Hammour KA, Rizik M, Aljanabi R, Alsakran L. Effect of educational intervention on healthcare providers’ knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience. Saudi Pharm J 2018;26:611-16.
14. Goel D, Farooq M. Impact of educational intervention on knowledge, attitude and practice of pharmacovigilance among interns. Adv Hum Biol 2017;7:75-9.
15. Singh J, Singh H, Rohilla R, Kumar R, Gautam CS. Lack of awareness of pharmacovigilance among young health-care professionals in India: An issue requiring urgent intervention. Int J App Basic Med Res 2018;8:158-63.
16. Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm J 2017;25:830-7.
17. Joubert MC, Naidoo P. Knowledge, perceptions and practices of pharmacovigilance amongst community and hospital pharmacists in a selected district of North West Province, South Africa. Health SA Gesondheid 2016;2:238-44.
18. Kalaiselvan V, Prasad T, Bisht A, Singh S, Singh GN. Adverse drug reactions reporting culture in pharmacovigilance programme of India. India J Med Res 2014;140:563-4.
19. The Pharmacy Council of India. Available from: http://www.pci.nic.in. [Last accessed on 2020 Mar 12].
20. Tew MM, Teoh BC, Baidi AS, Saw HL Assessment of knowledge, attitude and practices of adverse drug reaction reporting among doctors and pharmacists in primary healthcare. Adv Pharm Drug Saf 2016;5:206.
21. Sushma M, Kavitha R, Divyasree S, Deepashri B, Jayanthi CR. A questionnaire study to assess the knowledge, attitude and practice of pharmacovigilance in a paediatric tertiary care centre. J Chem Pharm Res 2011;3:416-22.
22. Garg P, Sharma V, Bajaj JK. Assessment of knowledge, attitude and practice of pharmacovigilance among the interns in a tertiary care hospital in northern India-a questionnaire based study. Int J Med Dent Sci 2017;6:1498-503.
23. Shakya GR, Shrestha D, Thapa R. Assessment on knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a tertiary hospital of Kathmandu. Nepal Med Coll J 2019;21:53-9.
24. PVPI: ADR Reporting Form. Available from: http://www.ipc.gov.in/ PvPI/adr.html. [Last accessed on 2020 Mar 01].
25. IPC-PvPI Guidance Document for Spontaneous Adverse Drug Reaction Reporting Version: 1.0. Available from: http://www.ipc.gov.in/PvPI/ pub/Guidance%20Document%20for%20spontaneous%20Adverse%20 Drug%20Reaction%20Reporting.pdf. [Last accessed on 2020 Mar 01].
26. Belete KA, Tessema TB. Health care professionals’ knowledge, attitude, and practice towards adverse drug reaction reporting and associated factors at selected public hospitals in Northeast Ethiopia: A cross-sectional study. Hindawi BioMed Res Int 2019;2019:8690546.
27. Subish P, Mohamed II, Pranaya M. Health professionals’ knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharm Pract (Granada) 2011;9:228-35.
28. Opadeyi AO, Réglat AF, Isah AO. Educational intervention to improve the knowledge, attitude and practice of healthcare professionals regarding pharmacovigilance in South-South Nigeria. Ther Adv Drug Saf 2019;10:1-12.
29. AlShammari TM, Almoslem MJ. Knowledge, attitudes and practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study. Saudi Pharm J 2018;26:925-31.
30. Katekhaye VM, Kadhe NG, John J, Pawar SR. Knowledge, attitude and practice of pharmacovigilance among medical professionals at a tertiary care hospital in Mumbai, Maharashtra, India. Int J Res Med Sci 2017;5:156-61.
31. Rajalakshmi R, Devi BV, Prasad TS, Swetha S, Dharini B. Knowledge, attitude and practice towards pharmacovigilance and adverse drug reaction reporting among nurses in a tertiary care hospital, Tirupati. IJPCR 2017;9:683-9.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.